Taeyoung Hwang

Title: Taeyoung Hwang: Innovator in Cancer Treatment

Introduction

Taeyoung Hwang is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of cancer research, particularly in the area of treatment and patient survival prediction. His innovative work has the potential to impact many lives.

Latest Patents

Taeyoung Hwang holds a patent titled "Use of the ZMIZ1 marker in directing treatment and predicting survival in cancer." This invention provides methods and compositions for treating cancer and predicting patient survival. The method involves obtaining a biological sample from the patient and detecting hypermethylation of ZMIZ1 using primers that specifically bind to CpG island 139 at the alternative promoter of the ZMIZ1 gene. This patent represents a significant advancement in cancer treatment methodologies.

Career Highlights

Hwang is affiliated with The Johns Hopkins University, where he continues to engage in groundbreaking research. His work is characterized by a commitment to improving cancer treatment outcomes through innovative scientific approaches.

Collaborations

Some of his notable coworkers include Dimitrios Mathios and Michael Lim. Their collaborative efforts contribute to the advancement of research in cancer treatment and patient care.

Conclusion

Taeyoung Hwang's contributions to cancer research through his patent and work at The Johns Hopkins University highlight his dedication to improving patient outcomes. His innovative methods have the potential to change the landscape of cancer treatment.